Assessing gene-gene interactions (GxG) at the gene level can permit examination of epistasis at biologically functional units with amplified interaction signals from markermarker pairs. While current gene-based GxG methods tend to be designed for two or a few genes, for complex traits, it is often common to have a list of many candidate genes to explore GxG. We propose a regression model with pathway-guided regularization for detecting interactions among genes. Specifically, we use the principal components to summarize the SNP-SNP interactions between a gene pair, and use an L1 penalty that incorporates adaptive weights based on biological guidance and trait supervision to identify important main and interaction effects. Our approach aims to combine biological guidance and data adaptiveness, and yields credible findings that may be likely to shed insights in order to formulate biological hypotheses for further molecular studies. The proposed approach can be used to explore the gene-gene interactions with a list of many candidate genes and is applicable even when sample size is smaller than the number of predictors studied. We evaluate the utility of the proposed method using simulation and real data analysis. The results suggest improved performance over methods not utilizing pathway and trait guidance.
Introduction
The focus of genetic association studies for complex diseases has been gradually shifting from assessing the main genetic effect to assessing interaction effects among genes (Cordell, 2009) . Complex diseases, such as hypertension, cancer, diabetes, and psychiatric disorders are believed to have a polygenic basis and gene-gene interaction (GxG) may play significant roles in disease etiology (Lin et al., 2013; Pillai et al., 2013; Koh-Tan et al., 2013; Howson et al., 2012; Ziyab et al., 2013) . Understanding GxG may also help to uncover missing heritability (Marchini et al., 2005; Evans et al., 2006) and to explain inconsistent findings from main-effect analyses (Hirschhorn et al., 2002) .
GxG can be defined from a biological view or a statistical view. The biological GxG refers to the physical interactions between biomolecules such as DNA, RNA or protein at the cellular level (Cordell, 2002) . The statistical GxG refers to a deviation from additive main effects of genes on a relevant scale. Although there were debates about the relationship between the two, evidence has shown that the statistical GxG and the biological GxG can converge to the same scientific process (Bush et al., 2009 ).
Differences in biological epistasis among individuals give rise to statistical epistasis, and hence statistical analyses can be used to infer the presence of gene-gene interactions (Moore & Williams, 2005) . For example, Bridges (1919) used a statistical model to identify genes with interaction effects on Drosophila eye color (Bridges, 1919) , and the corresponding biological mechanism that depicts how these genes influence biological pathways was understood many years later (Lloyd et al., 1998) . In this work, we propose a pathway-guided and trait-supervised procedure to further facilitate the detection of statistical GxG, and hope it can eventually lead to better understanding of biological epistasis and disease etiology.
Many methods have been proposed to detect GxG, such as logic regression (Kooperberg et al., 2001) , classification/regression tress (CART), multivariate adaptive regression splines (MARS) (Cook et al., 2004) , and methods building upon principals of multifactor dimensionality reduction (MDR) (Ritchie et al., 2003; Lou et al., 2007; Lou et al., 2008; Jestinah et al., 2011; Gui et al., 2013) . These methods have shown promising performances in detecting the interaction effects important to complex diseases or traits. (Ritchie, 2011; Steen, 2012; Dennis et al., 2011; Mackay, 2014) . However, most of these methods considered interactions among SNPs instead of interactions among genes. There are several advantages to assessing GxG at the gene level instead of at the SNP level.
First，genes are the basic units in the biological mechanism and SNPs within a gene tend to work together (Lehne et al., 2010; Kostem, et al. 2011) . Hence gene-level results can be more biologically insightful, easier to interpret, and more informative in revealing underlying mechanisms. Second, modeling multi-SNP information also incorporates linkage disequilibrium (LD) among SNPs in any downstream analysis such as association tests (He et al., 2011) . Third, the polygenic nature of complex diseases suggests moderate effect sizes for individual variants. Aggregating SNP effects at the gene level can amplify the signals and make them more detectable; it can also overcome etiological heterogeneity across individuals where the increased risk of different individuals is caused by different variants of the same gene. Finally, by using appropriate dimension reduction to summarize multi-SNP information, gene-level GxG methods are able to use fewer degrees of freedom, which further helps to improve power over SNP-level analyses. For these reasons, several gene-level methods for GxG have been proposed, such as the Turkey 1-df method (Chatterjee et al., 2006) , principal component (PC) analysis and the partial least square (PLS) based model (Wang et al., 2009) , kernel-based regressions (Larson & Schaid, 2013) , and the nonparametric test based method (Aschard et al., 2013) .
These studies suggested that gene-level methods have higher power in detecting GxG than traditional SNP-SNP strategies, especially when the causal SNPs are not directly genotyped.
Most of the methods available for studying GxG interactions are for two or a few genes. However, for complex traits, it is often common to have a list of many candidate genes in order to explore GxG. Even with a moderate size gene set, there can be a huge number of GxG terms even at the gene level; e.g., a set of 10 genes would lead to 45 pairwise GxG interaction terms. Directly modeling all GxG interactions would be inefficient due to computational challenge and lack of power. The solution is to reduce the search space of GxG by filtering out potentially unimportant genes (Ritchie, 2011) .
In current practice, the GxG search space is reduced either in a trait-supervised fashion or by using prior biological information.
To reduce the GxG search space supervised by the trait information, one would first apply main-effect association tests on each gene/SNP to remove unimportant ones and 6 then model interactions among the remaining ones (Wu et al., 2010) . Two interaction mechanisms for Amyotrophic Lateral Sclerosis (ALS) have been identified by this method (Sha et al., 2009 ). However, filtering out genes/SNPs through main-effect screening would have low power if the causal genes only have strong interaction effects but no main effects. To improve on this method, several non-parametric methods were proposed to perform more effective filtering, such asthe ReliefF (Robnik-Sikonja & Kononenko, 2003) and Tuned ReliefF (TuRF) methods (Moore & White, 2007) , which use the nearest neighbors method to find the important genes. The nearest neighbor of an individual is the one which has the highest genetic similarity with the target individual at the genes upon which the study is focused. If the gene is important to the trait, the nearest neighbor pair tends to have similar traits. ReliefF sums up all the weighted trait differences to test whether one gene is important to the trait. These methods can successfully reduce the search space by eliminating unimportant genes/SNPs and retaining important ones that may be missed by main-effect screening (Cordell, 2009) .
Another way to reduce GxG search space is to use biological knowledge or prior knowledge as a filter (Ritchie, 2011) , such as Biofilter (Bush et al., 2009) . Biofilter builds the list of important genes based on databases such as the Kyoto Encyclopedia of Genes and Genomes (KEGG), Protein interaction database (PID) and Biocarta (http://www.biocarta.com). Its underlying rationale is that if the interactions among a group of genes are supported by more biological evidence, the corresponding statistical finding for GxG is more credible. Biofilter uses an implication index, which is the number of databases supporting a focused GxG, to quantify the strength of biological support. If no database provides support to the focused GxG, it would be removed from the search space. Recent studies have shown that Biofilter can effectively reduce the GxG search space and result in biologically meaningful GxG findings (Pendergrass et al., 2013; Turner et al., 2011; Bush et al., 2011) .
Statistical analyses coupled with biological guidance can lead to credible findings that have both biological and statistical support and that may be more likely to shed insight on the formation of follow-up biological hypotheses for further cellular and molecular studies. However, directly filtering out genes without incorporating trait information can be too arbitrary, especially when the prior knowledge is not trait-specific.
In this paper, we propose a penalized method that incorporates biological guidance and trait supervision to detect GxG at the gene level. Specifically, we apply PC analysis to summarize the multi-SNP genotypes and SNP-SNP interaction between a gene pair, and to identify important main and interaction effects using an L1 penalty, which incorporates adaptive weights based on association strength and trait-specific pathway supports. We demonstrate the utility of pathway-guided penalized regression for GxG identification using simulation and real data analysis. where N is the sample size. Finally assume that there are genes, and the total number of GxG among these genes is = ( − 1)/2.
Methods

Obtaining gene-level genetic information
We first summarize the multi-SNP information at gene level for the main-effect design matrix and the interaction-effect design matrix by a PC analysis. . For quantitative traits, we set ( ) = , i.e., the identify link function. For binary traits, we set ( ) = log( /(1 − )) , i.e., the logit link function, which is commonly used in practice.
To detect important terms, we estimate and by minimizing the following penalized log-likelihood
where ( , ; , 1 , 2 ) is the likelihood function of and ; 1, 's and 2,ℓ 's are the weights for main effects and interaction effects, respectively; 1 and 2 are the tuning parameters of main effects and interaction effects, respectively. The weights (either the weight for main effect 1 or interaction effect 2 ) are constructed based on three components: weights based on gene size (denoted by ), weights based on pathway supports (denoted by ℎ ) and weights based on effect size on the trait (denoted by ). That is, the overall weight is = , ⋅ ℎ, ⋅ , .
Weights for gene size
In gene-set association analysis, it has been noted that larger genes (i.e., genes with more SNPs) are more likely to be chosen as significant (Wang et al., 2010) . Although here we summarized the gene information into the first PC, our results indicated that large genes tended to be selected if no penalty was imposed on large genes (e.g., we obtained higher false positive rates (FPR) for larger genes when = 1 , as can be seen in Fig. 1 ). This is probably related to the observation that the variation captured by the first PC decreases as the gene size increases (e.g., Table 1 ). On the other hand, incorporating gene size in the penalty weights can make false positives (FPs) less concentrated in the category of pairs of large genes. We note that while conventionally, gene size refers to the number of SNPs in a gene, in our work, gene size refers to the number of columns in the corresponding design matrix, e.g., or ℓ . Specifically, we set , = 1 + ( − min{ })/(max{ } − min{ }), where for main effect, is the number of columns of and for interaction effect, is the number of columns of . To coordinate with other weights (i.e., ℎ and ) and to avoid dominating other weights, we consider the rescaled − min{ } and divide it by max{ } − min{ } so that is between 1 (no size weight) and 2 (maximum size weight). In other words, the maximum penalty from gene size is bounded at 2 times the minimum penalty.
Weights for pathway support ℎ
We use weight ℎ to incorporate the strength of pathway support. We focus only on biological evidence relevant to the trait of interest (e.g., via PubMed search) and quantify the support strength by the number of pathways that support the interaction among certain gene pairs. Define ℎ as the total number of pathways related to the trait and ℓ is the number of sources supporting the ℓth gene-gene pair. We set
so that a gene pair with greater pathway support receives less penalty. Because our focus is on GxG effects, we set ℎ, = 1 for main effect terms. The value of ω ℎ is between 0.5 and 1 to avoid the dominance of one weight over the other.
Weight for effect size
Weight is the adaptive weight (Zou, 2006) that inversely weighs each effect term by an initial estimate of the effect size, i.e., , = 1/ |̃ | for the main effect terms and ,ℓ = 1/| l | for interaction terms. As a result, important terms receive a smaller penalty and tend to be retained in the selecting process while unimportant terms receive a larger penalty and are more likely to be eliminated. We use the iterative L1 penalty method (i.e., the multi-step adaptive lasso of Buhlmann and
Meier (2008)) to obtain the initial estimates ̃ and l . Specifically, ̃ and l are obtained by minimizing:
where ( ) and ℓ ( ) are the estimate for the m-th main effect and ℓ-th interaction effect in the t-th iterative. The difference between Equations (1) and (2) is that in Equation (2), the adaptive weights of the current iteration are the estimates from the previous iteration.
The iteration continues until and ℓ converge for all and ℓ. Using a penalized estimator method allows us to obtain the initial estimates even when the sample size is smaller than the total number of variables, and the iterative procedure yields more accurate estimates (Li & Sillanpaa, 2012) . The estimates for some (potentially unimportant) variables can be 0 with the L1 penalty. When that occurs, we set ̃= min (min >0 , 10 −3 ) and use similar treatment for l as well.
Computing tuning parameters
For a given value of ( 1 , 2 ), we compute the L1-reguralized estimates of and ℓ , and calculate the Bayesian information criterion (BIC) = −2 log (̂,̂; , 1 , 2 ) + log for the corresponding model, where is the number of terms retained in the model. The ( 1 , 2 ) that gives the smallest BIC is used to obtain the final model. We use BIC to tune 1 and 2 because our goal is to select the true model structure and BIC has the consistency property in model selection (French et al., 2006; Guo & Lin, 2009; Hastie et al., 2009; Lake et al., 2003) .
Simulation
We use simulation to evaluate the performance of the proposed method and the impact of different choices of weights. We performed two sets of simulation. Simulation I was based on a well-controlled hypothetical dataset with the sample size much larger than the number of predictors. It aimed to determine the optimal forms of the weights and to enable us to understand the impact of different weight specifications. Simulation II was based on the Wellcome Trust Case-Control Consortium (2007) data for Crohn's disease with the sample size smaller than the number of predictors. It aimed to evaluate the utility of the proposed approaches under realistic settings.
Simulation I
Design of Simulation I
In Simulation I, we generated 11 genes with different sizes (Table 2 . The genes were labeled as gene A to gene K, and the number of SNPs in each gene was randomly determined from a uniform (1, 100) distribution. The minor allele frequency (MAF) of a SNP was randomly determined from a uniform (0.1, 0.5) distribution. The SNPs within each gene were sorted by their MAF and only the middle 50% were used as causal SNPs.
In our simulation, genes with ≤30 SNPs were labeled as small (S), genes with ≥70 SNPs were labeled as large (L), and genes with 30 ~ 70 SNPs (exclusively) were labeled as medium-sized genes (M). We considered six categories of gene-gene pairs: SS, SM, SL, MM, ML and LL.
We generated trait value from Model (3) below, where we assumed that gene F has the main causal effect and there exist causal interaction effects between genes and (i.e., two small genes), between genes and (i.e., a small gene and a large gene), and between genes and (i.e., two large genes):
where , is the genotype of SNP in gene for subject and is generated from (0,1). Coefficients , , and are effect size; in the simulation, we used a common value for these coefficients and the common value was determined so that the partial 2 explained by interactions was around 30%. The partial 2 of the interaction effect is defined as 2 = ( 12 2 − 1 2 )/(1 − 1 2 ), where 12 2 is the R-square value for Model (3) containing both main and interaction effects, and 1 2 is the R-square value for Model (3) containing only main effects (i.e., = 0 for all and ). The total number of relevant pathways was 20. In each replication, we simulated 1500 individuals and performed 200 replications per scenario.
To assess the impact of a weight type, we performed the analyses under two conditions: (a) setting the corresponding weight type as 1 (i.e., neutral weights) and (b) incorporating the proposed weight type. For example, to assess the impact of ℎ , we examine the performance of (a) using + (a) vs. the performance of (b) using
For each condition, we computed the true positive rate (TPR) of detecting the causal GxG gene pairs. We also computed the FPR among the non-causal gene pairs. Finally, we calculated the statistic (Athanasiou, 2011), which is defined as = log − log and is commonly used as an omnibus index to integrate TPR and FPR. Higher indicates better performance of the method.
Results of Simulation I Assessment of (Figure 1)
When evaluating , we set the number of pathways supporting each interaction pairs as 20, 10, and 0 for × (MS gene pair), × (ML gene pair) and × (LL gene pair), respectively. We considered , = 1 (i.e., no gene size weights) and
where is the number of columns in the design matrix. The results indicated that without penalizing the gene size, the FPRs for large genes were substantially larger than the FPRs for small genes, e.g., the FPRs of LL pairs were higher relative to MM pairs and to ML pairs. By setting as proposed, the FPRs became less clustered in the large gene pairs, i.e., the FPRs in LL, ML and MM pairs decreased, the FPRs for SL pairs remained similar, and the FPRs for gene pairs not involving large genes (e.g., SS and SM) increased slightly. For TPR, we observed that the TPR deceased as the gene size increased, which is because , and were set to be the same and the number of pathway supports happen to decrease as gene size increases. By comparing the TPR with and without , we see that the TPR increased slightly for × (MS pair), and decreased slightly for × (ML pair) and for × (LL pair). This is because encouraged the model to select smaller terms, although the differences were small. According to the statistic, adding a size penalty always increases the overall performance.
Assessment of ℎ (Figure 2)
Our proposed weight for pathway support has a general form of ℎ,ℓ = 1 − However, there is a slight increase in FPR in the little and moderate support scenarios compared to using the null pathway weight. This is likely because under those two scenarios, the majority of the pathway supports are assigned to the null GxG gene pairs (i.e., the last column of Table 3 ). Overall, it is worth incorporating the pathway weights ---the gain in the statistic caused by ℎ in moderate and strong supports is substantially more than the loss in little supports, and the scenario of little support might occur less frequently in reality.
Assessment of (Figure 3)
When evaluating , we set the number of pathways supporting each interaction pair as 20, 10, and 0 for × , × and × , respectively. We compared the performance of four different ways to obtain the adaptive weights: (1) using the effect estimates from the iterative L1 penalty (L1), (2) using = 1 (null weights), (3) using the effect estimates from linear regression (LR), and (4) using the effect estimates from penalized L2 regression (L2). The other two weights, i.e., ℎ and , were specified using the proposed form. Figure 3 suggests that a null weight can lead to high TPR and high FPR and can result in a low D value. All three estimating methods yielded similar TPRs but different FPRs. The iterative L1 penalty method had the smallest FPR and was the best choice among the methods. In contrast, the linear regression had the worst performance, and it is infeasible when the number of variables exceeds the number of samples. The L2 penalty method had an FPR slightly smaller than that of the linear regression method.
Simulation II
Design of Simulation II
In Simulation II, we used the data for Crohn's disease from the Wellcome Trust CaseControl Consortium (WTCCC) (2007) We simulated 200 replicated datasets with 1500 subjects per replications. We assigned two genes as causal main-effect genes and another 10 gene pairs (different from the causal main-effect genes) with causal interaction effects. We sorted the SNPs within a causal gene by their MAFs and used the middle 50% SNPs as causal. To generate phenotype, we set
, where , ∈ { , , } is the genotype of the causal SNP in gene . For quantitative trait, we set ( ) = and generated from ( , ) with = and the values of 's and 's such that the partial contributed from the interaction effects was around 30%. For binary trait we set ( ) = ( − ) and generated from Bernoulli( ).
Parameter was set to make the prevalence around 7%. Similar to quantitative traits, the values of 's and 's were determined so that the partial from the interaction effects was around 30%. For binary traits, we used Nagelkerke (Nagelkerke, 1991) which is
where is the log-likelihood of the logistic regressions containing both main and interaction effects, and is that of the logistic regression containing only main effects. For each replication, we oversampled cases so as to obtain a balanced case-control sample (i.e., 750 cases and 750 controls).
We considered three scenarios as listed in Table 4 by carefully selecting 10 interactive gene pairs to evaluate the performance of the proposed procedure. Its performance was benchmarked against the penalized regression with only gene-size weight. In the "no support" scenario, most of the causal gene pairs were with 0 pathway support. In "random support" scenario, we randomly selected 10 gene pairs as causals.
In the "strong support" scenario, which was the opposite of the "no support" scenario, the 10 causal gene pairs were selected from those with strong pathway support. For each scenario, we computed the TPR across the 10 gene pairs, the FPR across the non-causal gene pairs, and the D statistics.
Results of Simulation II
With the real data based Simulation II, we first examined the performance of different weighting schemes for quantitative traits (Figure 4 ) and binary traits ( Figure 5 ). We also evaluated the performance of different PC strategies for summarizing the interaction information of a gene pair ( Figure 6 and Table 1 ). Finally, we explored the possible reasons of high FDRs for large genes (Table1). For binary traits (Fig. 5) , the results are similar to the quantitative traits. While FPRs were also retained around 0.002~0.003, the TPRs were smaller, at about 70% of the TPRs for the quantitative traits. This is not unexpected because binary trait values contained less information than quantitative trait values.
Evaluating different weighting schemes
Evaluating different PC strategies for summarizing interaction information
Under the setting of Figure 4 (i.e., Simulation II, quantitative traits), we evaluated the performance of using the first PC (referred to as PC1) and using the top few PCs that explained 80%
of variation (referred to as PC80). Because there are multiple PCs for a gene pair in PC80, we use group lasso (Yang and Zou, 2012) to select important gene pairs by setting a group as a gene pair. The results are shown in Figure 6 . We observe that PC80 had higher TPR than PC1; yet it also had higher FPR than PC1. The resulting D statistics are lower for PC80 than that of PC1. The results are not unexpected: although PC80 captured more information than PC1, the number of variables in PC80 also increased dramatically. On average, the number of interaction terms increased from ~3K for PC1 to ~35K for PC80.
The relative performance of PC1 and PC80 seems to reflect a tradeoff between the degrees of freedom spent and the information captured with a moderate sample size ( =1500). Table 1 , from which we see that 1 × captured higher amount of variation than 1 × 1 , and the difference increases as gene size increases. We also observed that the FPRs of 1 × were smaller than those of 1 × 1 , which is not unexpected because when the amount of information retained in the PCs became less, it became harder for the proposed algorithm to separate the noise from the signals.
Evaluating FDRs of different gene-pair sizes
Using the scenario of random support in Figure 4 , we further examined the FPRs of different gene sizes when using the size weight (i.e., setting as proposed) and when not using the size weight (i.e., setting = 1). The genes are classified into small size (1~33 SNPs), medium size (34~67 SNPs) and large size (68~102 SNPs), hence there are six size-categories for the gene pairs: SS, SM, SL, MM, ML and LL. From Table 1 , we see that when setting = 1, the FPR increased as the gene size increased, which again is probably due to the fact that the variation captured by the first PC decreases as the gene size increases. When the amount of variations captured by the PCs became smaller, the information content that can be used to detect GxG signals became less and may result in higher FPRs for large genes. When setting as proposed, the FDRs for gene pairs with non-large sizes stayed similar, but the FDRs for gene pairs involving large genes were reduced.
Real Data Analysis
Crohn's disease, also known as Crohn's syndrome and regional enteritis, is a type of inflammatory bowel disease that may affect any parts of the gastrointestinal tract from mouth to anus, causing a wide variety of symptoms. Crohn's disease is a complex genetic disease and many studies have been carried out to find the genetic factors responsible (Holmans et al., 2009 ).
We applied our approach to the WTCCC genome-wide association dataset for by Affymetrix. We focused our analysis on the two important pathways to Crohn's disease (Wang et al., 2010) , the IL-12 and STAT4 pathway and the T cell receptor pathway. As mentioned in the design of Simulation II, there were 76 genes from the two pathways with three genes involved in both pathways, nine genes only in the IL-12 and STAT4 pathway, and 64 genes only in the T cell receptor pathway. We extracted the SNPs of the 76 genes and removed SNPs with MAF smaller than 1%. We performed the analysis using the proposed method (i.e., incorporate all weights) and the benchmark method (only incorporate gene-size weight in the penalty). The significant genes and gene pairs are listed in Table 5 . For GxG effects, we also listed the number of supporting pathways. For the proposed method, many significant gene pairs identified contain the GRB2 gene. GRB2 has been found to be significant in Crohn's disease (Lee et al., 2011 , Vaughan et al., 2013 ; it encodes the protein GRB2, which is an adaptor protein involved in signal transduction and cell communication. Compared to the proposed method, the benchmark methods found two more GxG pairs with 0 pathway support and did not detect four of the GxG pairs with pathway support. Such results agreed with the simulation study in the sense that the proposed method may discourage the detection of GxG with no pathway support when the data suggested so.
Discussion
In this work, we proposed a pathway-guided approach for detecting interactions among genes. We constructed a weighted L1 penalty to select the important gene effect and gene-gene interactions; the weights were based on the number of pathways supportive of the effects as well as the estimated effect size. The numerical studies suggested an improved performance over the methods without using the guidance from pathway support and effect strength. The proposed approach can be used to explore gene-gene interactions with a list of candidate genes and is applicable even when sample size is smaller than the number of predictors studied. Although in theory the proposed method can handle an arbitrary number of genes, the number of GxG interactions increases exponentially with the number of genes. Therefore, our approach would be more suitable 24 for studying GxG effects among a list of pre-selected genes, such as genes from certain relevant pathways, rather than for whole genome analysis.
Our approach aims to combine the advantages of biological guidance and trait supervision in association detections; we achieve this by formulating these two strategies that are commonly used for reducing the GxG search space as the prior weights so as to regularize the GxG detection (as opposed to using these criteria as "filters"). Our results suggested that both types of weights are necessary, i.e., both ℎ and were necessary to obtain a robust D gain for the proposed method across different scenarios. Using ℎ would increase the TPR for the causal GxG interactions which have strong pathway support. However, it may also decrease the TPR for those GxG effects with little or no pathway support. For these scenarios, incorporating gives the power to identify novel GxG effects even for those with no known biological supports, i.e., it minimizes the TPR reduction and sometimes even boosts the TPR because it encourages pairs with non-zero GxG effects to be selected in the model.
When constructing our algorithm, we intended to use biological knowledge to guide, instead of force, the detection of interactions. We used three strategies to assure this goal.
First, we incorporated the biological knowledge as prior information instead of as a filter in the statistical inference. Second, we constrained the range of ℎ between 0.5 and 1 so that ℎ did not overwhelm other weights and yet could still encourage the algorithm to select the gene pair when the data are consistent with this prior information. Finally, we also used the data-adaptive weight based on the empirical effect size to safeguard the validity of the findings if inappropriate biological knowledge is used. The practice of using pathway knowledge to guide variable selection is based on the presumption that the pathway knowledge can reflect the underlying biological mechanisms. However, it is likely that the pathway structures depend on phenotypes and hence the "canonical"
pathway information would only represent the status of healthy controls. From this point of view, treating the biological information as prior knowledge and performing data adaptive selection can provide robustness against vague information and can minimize false positive and false negative findings.
In reality, different pathways often have substantial overlaps, and our method intends to make use of such overlapping. Specifically, we treat these overlapping pathways as separate pathways, and then for a given gene pair ℓ, we obtain ℓ , the number of pathways that contain gene pair ℓ. The rationale is that a gene pair that is involved in multiple pathways tends to be more biologically important and has a higher chance of interaction. On the other hand, such pathway support is only incorporated as prior information, which will encourage our algorithm to select the gene pair only if the data are consistent with it. In addition, we also incorporate the adaptive weight based on the empirical effect size to guide the variable selection, which provides another layer of Prior biological information (such as Biofilter) is often available at the gene or the higher pathway level. Hence one of the advantages to study interaction at gene level is that the prior knowledge and the effect assessment are aligned at the same level (genes).
However, the corresponding findings are also limited at gene-level resolution.
Therefore, a complete GxG study may require two steps; first performing a gene-level screening using the methods as proposed to identify interactive gene pairs, and then using those approaches that can provide the SNP×SNP level of resolution to follow up on the significant gene pairs and comprehend the sources of gene-level signals.
In our method, we summarize the information of gene-gene interaction using the PCs. Alternatively, Wang et al. (2009) apply PLS to summarize the gene information at gene level, which aims to maximize both the SNP-SNP correlation and the SNP-trait correlation. Performance of GxG tests using leading components from PLS was shown to be superior to using PCs from PCA (Wang et al., 2009 ). However, because PLS components were formed by maximizing their correlations with trait values, the corresponding GxG terms tend to stay significant even with no true interaction effects.
Besides using PCA vs. PLS, our method also differs from Wang et al. (2009) In this paper, we only used the pathway membership in the variable selection process.
There exist other types of information, such as pathway structure, the regulation relationship between genes, protein interaction, RNA networking or metabolite information, which can provide valuable guidance in the exploration of gene-gene interaction in a large search space. Further study will be required to appropriately formulate biological knowledge from multiple resources into the most appropriate statistical model in order to lead to efficient variable selection. Table   3 ). In each scenario, the dark gray bars represent the results of incorporating pathway support (i.e., setting ℎ as proposed) and the light gray bars represent the results of no pathway support (i.e., setting ℎ = 1). Table 4 , i.e., the causal gene pairs do not have much pathway support (no support), have strong pathway support (strong support), and the causal gene pairs that are randomly selected (random support). Given a certain scenario, the bars (from left to right) represent the results of using all weights (i.e., size-effect-and-pathway), size-and-pathway, size-and-effect, and size only. Table 4 , i.e., the causal gene pairs do not have much pathway support (no support), have strong pathway support (strong support), and the causal gene pairs that are randomly selected (random support). Given a certain scenario, the bars (from left to right) represent the results of using all weights (i.e., size-effect-and-pathway), size-and-pathway, size-and-effect, and size only. 
